The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Drs. von Ranson and Kaye Reply

To the Editor: Drs. Fava and Raffi’s suggestion that the rollback phenomenon might account for the occurrence of OCD symptoms in individuals who had recovered from bulimia nervosa is interesting and thought provoking. In the rollback phenomenon, prodromal symptoms recapitulate in reverse order as an episode remits, diminishing in severity as the disorder wanes (Detre and Jarecki, 1971). However, in our study, we did not find any differences in OCD symptoms between ill and recovered women with bulimia nervosa. This observation suggests that these apparently persistent and stable OCD symptoms may be better described as trait-like, rather than as prodromal and residual symptoms that arise only in association with an episode of bulimia nervosa. Although it is interesting to speculate about the role of OCD symptoms in the course of bulimia nervosa, ultimately the questions raised require further study. In particular, longitudinal research is needed to determine the course of OCD symptoms in individuals with bulimia nervosa, as well as the nature of the relationship between OCD symptoms and eating disorder symptoms. We agree that it is important to focus treatment efforts on persistent, subclinical symptoms associated with bulimia nervosa, such as OCD symptoms, as such treatment may alleviate patient distress. Furthermore, such treatment may reduce the likelihood of recurrence if, as Drs. Fava and Raffi suggest, subclinical symptoms play a role in perpetuating the eating disorder pathology.